Bernstein Reiterates Outperform on Beam Therapeutics Inc (BEAM) Amid Positive AATD Data
Tweet Send to a Friend
Bernstein SocGen Group analyst William Pickering reiterated an Outperform rating and $37.00 price target on Beam Therapeutics Inc (NASDAQ: BEAM).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
